89bio is a clinical-stage biopharmaceutical company that develops innovative therapies for patients with liver and cardiometabolic diseases. The company utilizes its expertise in…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see 89bio →Already a subscriber? Sign in
Xcout Intel tracks 89bio continuously — this profile deepens as new filings, funding, people and hiring data arrive.